###begin article-title 0
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 69 72 69 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 157 161 157 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 169 173 169 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN1">*</xref>
###xml 174 174 174 174 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="sbox.jpg"/>
###xml 174 174 174 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><inline-graphic xlink:href="sbox.jpg"/></sup>
###xml 174 174 174 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN2"><sup><inline-graphic xlink:href="sbox.jpg"/></sup></xref>
Epidermal Growth Factor Receptor Phosphorylation Sites Ser991 and Tyr998 Are Implicated in the Regulation of Receptor Endocytosis and Phosphorylations at Ser1039 and Thr1041*
###end article-title 0
###begin p 1
###xml 559 562 559 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 570 573 570 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 1243 1247 1243 1247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 1255 1259 1255 1259 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
###xml 1600 1607 1600 1607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMBO J.</italic>
###xml 1659 1663 1659 1663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 1671 1675 1671 1675 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
###xml 1839 1842 1839 1842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 1847 1850 1847 1850 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 1855 1859 1855 1859 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 1868 1872 1868 1872 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
###xml 126 131 <span type="species:ncbi:9606">human</span>
Aberrant expression, activation, and down-regulation of the epidermal growth factor receptor (EGFR) have causal roles in many human cancers, and post-translational modifications including phosphorylation and ubiquitination and protein-protein interactions directly modulate EGFR function. Quantitative mass spectrometric analyses including selected reaction monitoring (also known as multiple reaction monitoring) were applied to the EGFR and associated proteins. In response to epidermal growth factor (EGF) stimulation of cells, phosphorylations at EGFR Ser991 and Tyr998 accumulated more slowly than at receptor sites involved in RAS-ERK signaling. Phosphorylation-deficient mutant receptors S991A and Y998F activated ERK in response to EGF but were impaired for receptor endocytosis. Consistent with these results, the mutant receptors retained a network of interactions with known signaling proteins including EGF-stimulated binding to the adaptor GRB2. Compared with wild type EGFR the Y998F variant had diminished EGF-stimulated interaction with the ubiquitin E3 ligase CBL, and the S991A variant had decreased associated ubiquitin. The endocytosis-defective mutant receptors were found to have elevated phosphorylation at positions Ser1039 and Thr1041. These residues reside in a serine/threonine-rich region of the receptor previously implicated in p38 mitogen-activated protein kinase-dependent stress/cytokine-induced EGFR internalization and recycling (Zwang, Y., and Yarden, Y. (2006) p38 MAP kinase mediates stress-induced internalization of EGFR: implications for cancer chemotherapy. EMBO J. 25, 4195-4206). EGF-induced phosphorylations at Ser1039 and Thr1041 were blocked by treatment of cells with SB-202190, a selective inhibitor of p38. These results suggest that coordinated phosphorylation of EGFR involving sites Tyr998, Ser991, Ser1039, and Thr1041 governs the trafficking of EGF receptors. This reinforces the notion that EGFR function is manifest through spatially and temporally controlled protein-protein interactions and phosphorylations.
###end p 1
###begin p 2
###xml 70 71 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 70 71 70 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="G1"><sup>1</sup></xref>
###xml 337 338 337 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 340 341 340 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 552 553 552 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 657 658 657 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 660 661 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1126 1130 1126 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 1286 1287 1286 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1287 1287 1287 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6"/>
###xml 1287 1287 1287 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7"/>
###xml 1287 1287 1287 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8"/>
###xml 1287 1287 1287 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9"/>
###xml 1287 1287 1287 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10"/>
###xml 1288 1290 1288 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
Upon activation by ligand, the epidermal growth factor receptor (EGFR)1 dimerizes, sometimes as heterodimers with other EGFR family members; is catalytically activated by reorientation of kinase region subdomains; becomes covalently modified by phosphorylation and ubiquitination; and interacts with a variety of intracellular proteins (1, 2). These events activate intracellular signaling cascades, and concurrently the dimerized receptors become internalized through endocytosis and then may be recycled to the cell surface or degraded in lysosomes (3). Systematic analysis of EGFR family phosphorylation-dependent protein interactions has been assessed (4, 5), and many of the known EGFR-interacting proteins can be categorized as functioning in cellular processes such as EGF-induced signal transduction and EGFR endocytosis and trafficking. Temporal analysis of tyrosine phosphorylation following EGF treatment of cells revealed groups of EGFR substrates with shared profiles of phosphorylation kinetics, including some that display rapid kinetics of phosphorylation accumulation and are involved in signal transduction (e.g. ERK kinase activation) and others that accumulate more slowly following ligand treatment and are involved in receptor internalization and down-regulation (5-11). Although advances in MS and the definition of phosphorylation-dependent protein-protein interactions have led to a greatly expanded view of EGFR function and regulation, our understanding of the biological consequences and spatial-temporal relationships of individual modifications is incomplete.
###end p 2
###begin p 3
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 440 443 440 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 444 445 444 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 444 445 444 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN3"><sup>2</sup></xref>
###xml 449 452 449 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">995</sup>
###xml 461 464 461 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 601 604 601 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 635 641 635 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 643 645 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 744 746 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 858 861 858 861 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 869 872 869 872 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 874 876 874 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 878 880 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 882 884 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 886 888 886 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 898 901 898 901 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">993</sup>
###xml 1007 1009 1007 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 355 360 <span type="species:ncbi:9606">human</span>
In a previous quantitative phosphoproteomics study aimed at the identification of drug-modulated changes in phosphorylation associated with the EGFR network, a cluster of three sites of phosphorylation in the EGFR carboxyl tail region was identified as affected by receptor stimulation by EGF and inhibited by the ATP-competitive EGFR inhibitor PKI166 in human A431 tumor cells and xenograft tumors (12). The three sites in the cluster, Ser991,2 Ser995, and Tyr998, are localized within a single tryptic peptide having the sequence MHLPSPTDSNFYR that spans residues 987-999. The phosphorylation of Tyr998 was first described by Stover et al. (12), whereas the two serine sites were shown previously to be phosphorylated by Heisermann and Gill (13). Numerous recent studies using different cultured cell models have verified the phosphorylation of EGFR at Tyr998 and Ser991 (10, 11, 14, 15), and Thr993 was also observed to be phosphorylated within this same region of the EGFR in EGF-stimulated HeLa cells (10). The modulation of these sites by EGF and the EGFR inhibitor implicates them in EGFR signaling and suggests that they may have utility as pharmacodynamic markers of EGFR activity. However, the function and importance of these sites, their modulation by kinases and phosphatases, and possible roles in EGFR function remain unknown.
###end p 3
###begin p 4
###xml 106 112 106 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 149 152 149 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 337 340 337 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 342 343 342 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 352 355 352 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 595 599 595 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1110</sup>
###xml 604 608 604 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1172</sup>
###xml 617 621 617 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1197</sup>
###xml 686 689 686 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 731 732 731 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 771 774 771 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 785 788 785 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">993</sup>
###xml 810 812 810 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 858 861 858 861 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 869 872 869 872 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 989 991 989 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1502 1504 1498 1500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1699 1701 1695 1697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1830 1834 1826 1830 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1069</sup>
###xml 1974 1976 1963 1965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 2122 2124 2111 2113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
Several amino acid residues in the EGFR have been implicated in the regulation of its trafficking. Sorkin et al. (16) showed that substitution of Tyr998 with phenylalanine rendered high density EGFRs defective for endocytosis and interaction with AP-2. More recent kinetic studies using MS indicated that EGFR phosphorylation at both Tyr998 (5) and Ser991 (10) occurs relatively slowly compared with other EGF-induced tyrosine phosphorylations known to be involved in receptor-proximal signal transduction. For example, Mann and co-workers (10) recorded maximal phosphorylation at EGFR sites Tyr1110, Tyr1172, and Tyr1197 at 1 min post-EGF, whereas EGF-stimulated phosphorylation at Tyr998 was still increasing at 15 min post-EGF (5), and a peptide containing both Ser(P)991 and Thr(P)993 peaked after 10 min (10). However, the role of phosphorylation at Tyr998 and Ser991 has not been reported. Another region of the EGFR, spanning residues 1026-1046, was identified by Zwang and Yarden (17) as a target of phosphorylation downstream of the stress-activated mitogen-activated protein (MAP) kinase p38 and associated with transient internalization and recycling of the EGFR in response to cytokine (TNFalpha) and stress challenges such as UV irradiation and the chemotherapeutic agent cisplatinum. Within this part of the receptor, a 13-residue section spanning 1029-1041 and the leucines at 1034 and 1035 in particular were found to be essential for ligand- and dimerization-induced EGFR endocytosis (18). Although both EGF- and stress-induced EGFR internalization may be clathrin-mediated, they differ in that the former leads to receptor down-regulation and involves the E3 ubiquitin ligase CBL (19), whereas the latter involves receptor recycling, is not associated with receptor phosphorylation at the CBL binding site Tyr(P)1069, and, in the case of TNFalpha treatment, involves activation of the transforming growth factor beta-activated kinase TAK1 upstream of p38 (20). Interestingly although p38 kinase is not required for EGF-induced EGFR internalization, it is required for CBL-dependent receptor degradation (21). Therefore, alternate pathways involving p38 kinase regulate the down-regulation or recycling of the EGFR in response to diverse extracellular signals. However, the molecular details that govern these two processes are not fully understood.
###end p 4
###begin p 5
###xml 141 144 141 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 152 155 152 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 547 550 547 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 558 561 558 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 727 731 727 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 739 743 739 743 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
###xml 789 792 789 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 818 821 818 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
In the current study, EGFR phosphorylation, signaling, protein-protein interactions, and trafficking were analyzed to address the role of Tyr998 and Ser991 in EGFR endocytosis. This was achieved by application of complementary methods including quantitative selected reaction monitoring (SRM, also known as MRM for multiple reaction monitoring) mass spectrometry, fluorescence imaging and cell sorting, immunoaffinity protein enrichment and blotting, and site-directed mutagenesis. Substitution mutations that prevented phosphorylation at EGFR Tyr998 and Ser991 did not prevent EGFR-to-ERK signaling but impaired EGF-induced receptor internalization and stimulated p38 kinase-dependent receptor phosphorylation at positions Ser1039 and Thr1041. These findings confirm the importance of Tyr998 and reveal a role for Ser991 in EGF-mediated EGFR internalization possibly involving cross-talk with the p38 kinase-dependent EGFR recycling pathway.
###end p 5
###begin title 6
EXPERIMENTAL PROCEDURES
###end title 6
###begin title 7

###end title 7
###begin title 8

###end title 8
###begin title 9
Constructs and Reagents
###end title 9
###begin p 10
###xml 50 53 50 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 68 71 68 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 486 488 485 487 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18</sub>
Site-directed mutagenesis was used to generate Tyr998-to-Phe and Ser991-to-Ala mutations in a construct encoding a chimeric EGFR-FLAG-GFP protein (22). For immunoprecipitation (IP) anti-FLAG-M2 was obtained from Sigma-Aldrich. For Western blotting, anti-FLAG and anti-Tyr(P) (4G10) were obtained from Sigma-Aldrich and Millipore (Billerica, MA), respectively. All other antibodies were obtained from Cell Signaling Technology (Danvers, MA). Toptips (200 mul) for preparing custom-made C18 tips were purchased from Canadian Life Science (Peterborough, Ontario, Canada). SB-202190 was from Sigma-Aldrich; all other chemical reagents were purchased from Sigma-Aldrich, and aqueous solutions were prepared using Milli-Q grade water (Millipore, Bedford, MA).
###end p 10
###begin title 11
Cell Culture and Cell Lysis
###end title 11
###begin p 12
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 676 677 669 670 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 701 702 694 695 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 748 749 741 742 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 758 759 751 752 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 947 948 940 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1032 1033 1024 1025 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1105 1106 1097 1098 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1165 1167 1157 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 146 152 <span type="species:ncbi:9913">bovine</span>
Human embryonic kidney 293 (HEK293) cells and lines derived from them were maintained in Dulbecco's modified Eagle's medium supplemented with 10% bovine serum. HEK-EGFR was derived from HEK293 and stably expresses chimeric EGFR as described previously (22). HEK293 derivatives stably expressing chimeric EGFR Y998F and S991A variants were derived by similar methods (22), and all EGFR-expressing transfectants were cultured as described above and including G418 (400 mug/ml). For IP and Western blotting, cells were deprived of serum overnight, treated with or without EGF (10 min, 100 ng/ml, 37 degreesC), then rinsed with ice-cold PBS, and lysed in Nonidet P-40 buffer (50 mm Tris-HCl, pH 7.5, 150 mm sodium chloride, 1% (v/v) Nonidet P-40, 100 mm NaF, 1 mm sodium orthovanadate, and protease inhibitors). In advance of MS analysis, prior to immunoprecipitation cell lysates were further clarified by ultracentrifugation for 60 min at 100,000 x g. For inhibition of p38 kinase, SB-202190 was used at a final concentration of 50 mum, a concentration at which it is not expected to affect ERK1/2, c-Jun NH2-terminal kinase (JNK), and several other related kinases (23).
###end p 12
###begin title 13
Fluorescence Microscopy and Flow Cytometry
###end title 13
###begin p 14
###xml 361 363 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
For fluorescence imaging cells were cultured to subconfluence, deprived of serum overnight, and then treated with or without EGF (100 ng/ml) for 60 min at 4 degreesC and then at 37 degreesC for 0, 5, or 15 min. Cells were then fixed (3.7% paraformaldehyde, 23 degreesC, 10 min), washed with PBS, and observed by fluorescence microscopy as described previously (24).
###end p 14
###begin p 15
###xml 264 270 258 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 272 274 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 317 318 311 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 626 637 <span type="species:ncbi:3704">horseradish</span>
For biotin labeling EGFR on the cell surface, cells were grown in 60-mm dishes to subconfluence, deprived of serum overnight, and then treated with or without EGF (50 ng/ml, 37 degreesC, 30 min). Biotinylation of intact cells was carried out as described by Zhang et al. (25). Briefly cells were suspended to 2.5 x 107 cells/ml in PBS (pH 8.0) and then incubated with 1.0 mg/ml sulfo-NHS-biotin (Pierce) at 23 degreesC for 30 min. Cells were then washed three times with PBS, lysed, and subjected to IP with immobilized anti-FLAG. Western blotting was performed as described below. The biotin detection agent was streptavidin-horseradish peroxidase.
###end p 15
###begin p 16
###xml 221 227 209 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 227 228 215 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 257 258 245 246 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 279 280 267 268 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 405 407 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
For flow cytometry, cells at 80% confluence were deprived of serum overnight and then incubated with rhodamine-EGF at 4 degreesC for 30 min. After washing, cells were incubated at 37 degreesC for various time points (see Fig. 4B). After an acidic wash (0.2 m acetic acid and 0.5 m NaCl, pH 2.8) to remove non-internalized EGF, the fluorescence emission of internalized EGF was detected by flow cytometry (26).
###end p 16
###begin title 17
IP and Western Blotting
###end title 17
###begin p 18
For IP-Western analysis of associated proteins, 2 mg of total cellular protein in clarified lysates were extracted with immobilized anti-FLAG beads (10 mul) overnight at 4 degreesC. Immunoprecipitates were washed three times with Nonidet P-40 buffer, and proteins were eluted with 30 mul of 2x Laemmli sample buffer. Following SDS-PAGE proteins were electrophoretically transferred to Immobilon-P membranes (Millipore), then developed by using chemiluminescence reagents, imaged with x-ray film (Eastman Kodak Co. XRP), and quantified by using a Fluor-S MultiImager (Bio-Rad). For direct Western blotting of lysates, 40 mug protein were loaded per lane.
###end p 18
###begin p 19
###xml 315 317 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
For MS analysis of IP samples, 5-fold more starting material (by protein amount) and 30 mul of anti-FLAG beads were used. Immunoprecipitates were washed three times with Nonidet P-40 buffer and twice with HPLC water and then eluted with 50 mul of 0.15% TFA. Proteins were further processed as described previously (22) and then analyzed as described below.
###end p 19
###begin title 20
Mass Spectrometry
###end title 20
###begin p 21
###xml 285 286 285 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 287 288 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
Samples were analyzed on a linear ion trap-Orbitrap hybrid analyzer (LTQ-Orbitrap, ThermoFisher, San Jose, CA) outfitted with a nanospray source and EASY-nLC split-free nano-LC system (Proxeon Biosystems, Odense, Denmark). The instrument method consisted of one MS full scan (400-1400 m/z) in the Orbitrap mass analyzer, an automatic gain control target of 500,000 with a maximum ion injection of 500 ms, one microscan, and a resolution of 60,000. Three data-dependent MS/MS scans were performed in the linear ion trap using the three most intense ions at 35% normalized collision energy. The MS and MS/MS scans were obtained in parallel fashion. In MS/MS mode automatic gain control targets were 10,000 with a maximum ion injection time of 100 ms. A minimum ion intensity of 1000 was required to trigger an MS/MS spectrum. The dynamic exclusion was applied using a maximum exclusion list of 500 with one repeat count with a repeat duration of 30 s and exclusion duration of 45 s.
###end p 21
###begin p 22
###xml 488 490 486 488 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18</sub>
###xml 975 976 973 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 977 978 975 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
SRM analysis was carried out by using a TSQ Quantum Ultra triple quadrupole MS instrument (Thermo Scientific) with a Proxeon source and LC system as described above except that the gradient time associated with the Orbitrap was 120 min and was 40 min with the TSQ instrument. Peptides were captured in a homemade 4-cm x 150-mum-inner diameter trapping column and eluted over a 20-cm x 75-mum-inner diameter fused silica analytical column. The packing material for both columns was Magic C18 (Michrom BioResources, Auburn, CA). The gradient was 0-65% acetonitrile in 0.1% formic acid over 35 min at 250 nl/min. The validated transitions for all phosphopeptides and unphosphorylated peptides for EGFR immunoprecipitates are listed in  and were monitored for the duration of the run. Most peptides were followed by using two unique transitions. Q2 gas pressure was 1.5 millitorrs, and collision energy was calculated relative to the precursor ion mass by the following formula: m/z x 0.034 V + 3 V. The scan width was 0.02 Da, and the dwell time was 10 ms. Q1 was operated at a resolution of 0.2, and Q3 resolution was 0.7. Xcalibur data acquisition software and SRM Builder software (Thermo Scientific) were used for data acquisition and total ion current calculations.
###end p 22
###begin title 23
MS Data Analysis
###end title 23
###begin p 24
###xml 292 297 <span type="species:ncbi:9606">human</span>
Tandem mass spectra were extracted by BioWorks version 3.3. All MS/MS samples were analyzed using SEQUEST (ThermoFinnigan, San Jose, CA; version 27, revision 12) and X! Tandem (The Global Proteome Machine Organization; version 2006.04.01.2). Both search engines were set up to search the IPI human database (version 3.18, 60,090 entries) assuming trypsin digestion, allowing two missed cleavages, and using a fragment ion mass tolerance of 0.5 Da and a parent ion tolerance of 0.02 Da. The iodoacetamide derivative of cysteine was specified as a fixed modification. The phosphorylation of Tyr was specified in SEQUEST and the phosphorylation of Tyr, Ser, and Thr was specified in X! Tandem as variable modifications.
###end p 24
###begin p 25
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
Scaffold (Proteome Software Inc., Portland, OR; version Scaffold-01.06.05) was used to validate MS/MS-based peptide and protein identifications. Peptide identifications were accepted if they could be established at greater than 95.0% probability as specified by the Peptide Prophet algorithm (27). Protein identifications were accepted if they could be established at greater than 95.0% probability as assigned by the Protein Prophet algorithm (28). Proteins that contained similar peptides and could not be differentiated based on MS/MS analysis alone were grouped to satisfy the principles of parsimony. The assignment of post-translational modifications was made by the search engines (described above) and verified manually. Modification by sulfation was not distinguishable from phosphorylation with the mass accuracy of these experiments. However, these isobaric modifications were assumed to be phosphorylation if anti-Tyr(P) enrichment was used for peptide purification.
###end p 25
###begin p 26
###xml 143 147 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 1013 1015 1013 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
Label-free relative quantification was approached by two methods. In the first, differential abundance was estimated based on spectral counts; i.e. the total number of peptides identified by MS/MS and assigned to a protein. For a given protein, the total non-phosphorylated peptides from four experiments were summed, and values were normalized according to non-phosphorylated EGFR peptide spectral counts (29, 30). In the second, peak areas of SRM transitions were determined by using SRM Builder prototype software (Thermo Scientific; version 1.0) after confirming for each peptide the co-elution of all transitions. The most abundant transition for each peptide was used for quantification unless interference in this channel was observed (32). For those cases, the second most abundant transition was used. Noise levels were estimated based upon visual inspection of signals preceding and following peptide peaks, and the signal-to-noise ratio was calculated by dividing peak intensity by the proximal noise (31). When the signal-to-noise ratio was less than 3 in a set of samples, these peptides were excluded in the protein quantification analysis.
###end p 26
###begin p 27
###xml 436 440 436 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 440 446 440 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 446 447 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 569 570 569 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
SRM intensities for associated proteins were divided by the value measured for the EGFR normalization peptide YSFGATCVK (residues 285-293; see "Results") intrinsic to that sample. Hence calculated associated protein amounts are per unit of EGFR. The assumption was made that the amount of EGFR in cells did not change significantly after 15 min of EGF stimulation or SB-202190 incubation. Western blot results verified this assumption (e.g.Fig. 1E). Results from three independently repeated experiments were used to calculate statistical significance by the Student's t test. A complete listing of SRM intensities including coefficients of variance are included in the .
###end p 27
###begin p 28
###xml 95 100 <span type="species:ncbi:9606">Human</span>
###xml 129 134 <span type="species:ncbi:9606">Human</span>
The data described in this paper will be made freely available through databases including the Human Protein Reference Database, Human Proteinpedia, Global Proteome Machine, PhosphoELM, and PhosphoSite.
###end p 28
###begin title 29
RESULTS
###end title 29
###begin title 30

###end title 30
###begin title 31

###end title 31
###begin title 32
###xml 28 31 28 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 42 45 42 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
EGFR Variants Lacking Tyr(P)998 and Ser(P)991 Are Competent for EGFR --> ERK Signaling but Defective for Endocytosis
###end title 32
###begin p 33
###xml 55 58 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 376 379 376 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 390 393 390 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">993</sup>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 491 494 491 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
The accumulation of phosphorylation at EGFR residue Tyr998 is documented to be relatively slow compared with other EGFR Tyr(P) sites when measured in HeLa cells (5), and our own experiments with HEK-EGFR cells are in agreement with these kinetics (data not shown). Similarly the kinetics of EGF-stimulated accumulation of a doubly phosphorylated EGFR peptide containing Ser(P)991 and Thr(P)993 was reportedly slow (10). In our experiments, the singly phosphorylated peptide containing Ser(P)991 was the most efficiently detected phosphoisomer of the MHLPSPTDSNFYR peptide.
###end p 33
###begin p 34
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 109 109 109 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33"/>
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 326 326 326 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36"/>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 400 403 400 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 525 531 525 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 531 532 531 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 538 544 538 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">arrows</italic>
###xml 621 624 621 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 732 738 732 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 740 741 740 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 746 747 746 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 879 881 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 976 978 976 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 1023 1026 1023 1026 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 1159 1165 1147 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 1165 1166 1153 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
The MS method of multiple reaction monitoring or SRM has been applied to quantify protein phosphorylation (32-34), including temporal analysis of Tyr(P) modifications associated with EGF treatment (8). The neutral loss of phosphoric acid from Ser(P) and Thr(P) sites is a frequent event during tandem MS of phosphopeptides (35-37), and the MS/MS spectrum of the EGFR tryptic peptide containing Ser(P)991 contained two prominent product ions representing loss of phosphoric acid from the parent ion and from the y10 fragment (Fig. 1A, see arrows). These neutral loss transitions were monitored as a means to measure Ser(P)991 following EGF stimulation of HEK-EGFR cells, and the duration of the EGF treatment was extended to 90 min (Fig. 1, B and C), which is longer than previous studies in which EGF-stimulated phosphorylation was monitored for up to 20 min post-EGF treatment (10). SRM analysis of neutral loss for phosphorylation measurement has been described previously (33). The SRM analysis indicated that the Ser(P)991 peptide increased approximately10-fold after 90 min of EGF treatment and did not appear to reach a plateau or maximum by this time (Fig. 1C).
###end p 34
###begin p 35
###xml 59 62 59 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 0 70 0 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Detection and quantification of phosphorylation at EGFR Ser<sup>991</sup> by SRM.</bold>
###xml 70 71 70 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 238 241 238 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 288 299 288 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 341 347 341 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arrows</italic>
###xml 510 511 510 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 649 650 649 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 651 652 651 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 663 664 663 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 708 709 708 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 710 711 710 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 722 723 722 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 746 747 746 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 748 749 748 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 761 762 761 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 827 828 827 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 956 966 956 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Error bars</italic>
###xml 1030 1031 1030 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1036 1037 1036 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 1053 1055 1053 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WB</italic>
###xml 1244 1248 1244 1248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1092</sup>
###xml 1250 1251 1250 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1310 1311 1310 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 1491 1493 1491 1493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pY</italic>
Detection and quantification of phosphorylation at EGFR Ser991 by SRM.A, trypsin-digested immunopurified EGFR was analyzed by high resolution LC-MS/MS (Proxeon LC/source; Thermo LTQ-Orbitrap). The MS/MS spectrum of the EGFR peptide MHLPpS991PTDSNFYR (where pS is phosphoserine) is shown (upper panel). The y and b series ions are indicated. Arrows point to product ions corresponding to parent - 98 and y10 -98 ions (as indicated), which reflect the neutral loss of phosphoric acid from the Ser(P) side chain. B, SRM LC elution profiles plotting the summed signal intensities of ions corresponding to singly phosphorylated MHLPSPTDSNFYR (precursor, m/z = 822.85, z = 2) transitioning to 1) precursor - 98/2 (m/z = 773.86, z = 2) and 2) y10 - 98 (m/z = 1165.50, z = 1) at various time points after EGF stimulation as indicated. C, histogram depicting the integrated SRM signal intensities normalized to a non-phosphorylated EGFR peptide in the same sample. Error bars indicate S.D. from three biological repeats of the experiment. D and E, Western blot (WB) analysis of whole-cell protein extracts from HEK-EGFR cells harvested following EGF treatment for the indicated durations. Antibodies specific to the EGFR phosphoepitope containing Tyr(P)1092 (D) or that recognize the FLAG epitope on EGFR-FLAG protein (E) were used to probe the filters, which were further developed with appropriate secondary antibody-enzyme conjugates and chemiluminescence imaging (see "Experimental Procedures"). pY, phosphotyrosine.
###end p 35
###begin p 36
###xml 56 60 56 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1092</sup>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 281 287 281 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 287 288 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 401 407 401 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 407 408 407 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 524 527 524 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 640 643 640 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 655 658 655 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">993</sup>
###xml 679 685 679 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 687 689 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1005 1011 1005 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1013 1015 1013 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
As a control, EGF-stimulated phosphorylation at EGFR Tyr1092, which is associated with GRB2 binding and activation of RAS-ERK signaling, was monitored by Western immunoblotting (38). As expected, phosphorylation at this position was rapid and reached an apparent maximum by 1 min (Fig. 1D). It was observed that even 90 min after EGF stimulation there was not yet appreciable down-regulation of EGFR (Fig. 1E), which is typically more apparent by 4 h post-EGF (21). The relatively slow accumulation of phosphorylation at Ser991 following EGF treatment was pronounced and differs from the kinetics of the doubly phosphorylated isomer (Ser(P)991 with Thr(P)993) described by Olsen et al. (10) that reached a maximum abundance near 10 min post-EGF and then receded to basal levels by 20 min. However, it is possible that the kinetics of these phosphorylations differ as a function of cell type and receptor densities, which are parameters that are different in our study and the comprehensive study by Olsen et al. (10).
###end p 36
###begin p 37
###xml 34 37 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 394 395 390 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 456 457 450 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
The SRM measurements of the Ser(P)991 peptide were normalized to the amount of a non-phosphorylated EGFR peptide YSFGATCVK (residues 285-293) from the same sample. The signal for this control peptide was generated by summation of transitions precursor --> y6 and precursor --> y7 at corresponding time points of EGF stimulation (). The EGFR control peptide produced a high signal (intensity >106 units) and low coefficient of variation (CV = 8.3 +/- 3.3%, n = 9) in test samples. Measurements of this peptide, therefore, were used as an indicator of EGFR amount in all SRM experiments in this study.
###end p 37
###begin p 38
###xml 54 57 54 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 65 68 65 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 401 404 401 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 432 435 432 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 603 607 603 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1092</sup>
###xml 712 716 712 716 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1092</sup>
###xml 771 777 771 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 779 780 779 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 785 786 785 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 942 948 942 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 950 951 950 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 956 957 956 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
The relatively slow kinetics of phosphorylation at Ser991 and Tyr998 suggested that these modifications might not be involved in rapid signaling events associated with EGFR activation. To test this, site-directed mutagenesis was used to remove the side chain hydroxyl groups at these positions to prevent phosphorylation. Transfected HEK293 cell lines stably expressing variant proteins containing Tyr998-to-Phe (EGFR Y998F) and Ser991-to-Ala (EGFR S991A) at levels comparable to wild type (WT) EGFR in HEK-EGFR were established. These cell cultures were monitored for EGF-induced phosphorylation at Tyr1092 and for activation (phosphorylation) of the downstream MAP kinase ERK1/2. Phosphorylation of EGFR at Tyr1092 was unaffected by either Y998F or S991A substitution (Fig. 2, A and B), and the two mutant receptors did not show statistically significant changes in phosphorylated ERK1/2 following EGF treatment when compared with WT EGFR (Fig. 2, C and D).
###end p 38
###begin p 39
###xml 27 31 27 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1092</sup>
###xml 0 135 0 135 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Phosphorylation of EGFR Tyr<sup>1092</sup> and ERK in EGF-stimulated HEK cells expressing wild type EGFR and the mutant receptors Y998F and S991A.</bold>
###xml 135 136 135 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 210 214 210 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 441 443 441 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WB</italic>
###xml 494 498 494 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1092</sup>
###xml 511 512 511 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 556 560 556 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1092</sup>
###xml 639 640 639 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 704 705 704 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 878 882 878 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pERK</italic>
###xml 884 895 884 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 923 934 923 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower panel</italic>
###xml 937 938 937 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1061 1062 1061 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1089 1093 1089 1093 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1092</sup>
###xml 1095 1096 1095 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1115 1116 1115 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1298 1300 1298 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pY</italic>
###xml 1319 1329 1319 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Error bars</italic>
Phosphorylation of EGFR Tyr1092 and ERK in EGF-stimulated HEK cells expressing wild type EGFR and the mutant receptors Y998F and S991A.A, EGFR-FLAG proteins from HEK cells stably expressing wild type receptor (EGFR) or the indicated variants (Y998F and S991A) were isolated by immunoprecipitation (anti-FLAG) at the indicated times following cell stimulation with EGF, then resolved by SDS-PAGE, and subjected to immuno- (Western) blotting (WB) with the indicated anti-FLAG and anti-EGFR-Tyr(P)1092 antibodies. B, the time course of phosphorylated EGFR Tyr1092 after EGF stimulation from four biological repeats of the experiment shown in A and based on quantification of chemiluminescence light output. C, whole-cell lysates of the indicated cell samples prepared after the indicated durations of EGF treatment were blotted with antibodies directed against phosphorylated ERK (pERK; upper panel) and unphosphorylated ERK (lower panel). D, the time course of ERK phosphorylation after EGF stimulation from four biological repeats and quantified as described in B. The levels of EGFR Tyr(P)1092 (B) and phospho-ERK (D) were normalized to their non-phosphorylated forms at corresponding time points, and the levels of phosphorylation after 1 min of EGF stimulation were arbitrarily regarded as 100%. pY, phosphotyrosine. Error bars indicate S.D. from four independent experiments.
###end p 39
###begin p 40
###xml 386 392 386 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 394 405 394 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">left panels</italic>
###xml 407 418 407 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">long arrows</italic>
###xml 653 659 647 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 661 670 655 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper row</italic>
###xml 672 684 666 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">short arrows</italic>
###xml 837 843 831 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 845 851 839 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">middle</italic>
###xml 856 866 850 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower rows</italic>
###xml 868 879 862 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">long arrows</italic>
###xml 1025 1031 1019 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1033 1035 1027 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
To examine endocytosis of WT EGFR and the phosphorylation-defective receptor variants, localization of chimeric receptors containing carboxyl-terminal green fluorescent protein (GFP) was monitored by fluorescence microscopy. In serum-starved HEK-EGFR, HEK-S991A, and HEK-Y998F cells, the receptors were concentrated near the cell periphery consistent with plasma membrane localization (Fig. 3, left panels, long arrows). After exposure to 100 ng/ml EGF and incubation at 37 degreesC for 5 and 15 min, WT EGFR staining at the cell margins was diminished and became internalized and concentrated into intracellular aggregates characteristic of endosomes (Fig. 3, upper row, short arrows). By contrast, Y998F and S991A mutant receptors displayed far less internalization/aggregation and remained largely concentrated at the cell periphery (Fig. 3, middle and lower rows, long arrows). These observations demonstrate defective endocytosis of the mutant receptors. The endocytosis defect of EGFR Y998F is expected based on Sorkin et al. (16). The cell staining was categorized into two types: WT-like, typified by internalized and aggregated receptors and little or no staining at the cell margins, and mutant-like, which lacked intracellular aggregates and retained concentrated staining at the cell margins. After tabulating these patterns in 100 cells in three separate experiments, approximately60% of WT receptors displayed the WT-like pattern of internalized receptors (diminished peripheral staining accompanied by internalized aggregates), whereas only approximately30% of Y998F and 25% of S991A receptors showed this pattern.
###end p 40
###begin p 41
###xml 0 87 0 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Spatial and temporal dynamics of wild type EGFR and phosphorylation-deficient variants.</bold>
###xml 332 343 326 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Long arrows</italic>
###xml 415 427 409 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">short arrows</italic>
###xml 532 541 526 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Scale bar</italic>
Spatial and temporal dynamics of wild type EGFR and phosphorylation-deficient variants. HEK293-based cells stably expressing WT, S991A, and Y998F EGFR proteins (as indicated) fused to GFP were treated with EGF (100 ng/ml) for 0, 5, and 15 min at 37 degreesC as indicated, then fixed, and localized by using fluorescence microscopy. Long arrows indicate staining at the cell periphery near plasma membranes, and the short arrows indicate regions of aggregated intracellular staining that may correspond to the endosomal compartment. Scale bar, 100 mum.
###end p 41
###begin p 42
###xml 357 363 357 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 363 364 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 593 599 581 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 599 600 587 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 756 762 744 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 762 763 750 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
To further examine and to quantify the extent of EGF-stimulated receptor internalization, cells were treated with or without EGF for 30 min, and then receptors exposed on the cell surface were covalently labeled with biotin. Receptors were then purified by immunoprecipitation and quantified for biotinylation by Western blotting with a streptavidin probe (Fig. 4A). After EGF treatment, the amount of surface-exposed, biotinylated WT EGFR was decreased by approximately50%, whereas the amounts of surface exposed Y998F and S991A receptors were almost equivalent to levels in untreated cells (Fig. 4A). As an additional measure of receptor endocytosis, receptor-mediated internalization of rhodamine-labeled EGF was measured by flow cytometry. As shown in Fig. 4B, ligand internalization by Y998F and S991A was less than that observed for WT EGFR. Therefore, by three different measures, the Y998F and S991A variants were defective for receptor endocytosis.
###end p 42
###begin p 43
###xml 0 35 0 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Quantification of EGFR endocytosis.</bold>
###xml 35 36 35 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 348 350 336 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WB</italic>
###xml 400 411 388 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower panel</italic>
###xml 508 519 496 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 522 523 510 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 770 771 758 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 784 785 772 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 795 805 783 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Error bars</italic>
###xml 424 435 <span type="species:ncbi:3704">horseradish</span>
Quantification of EGFR endocytosis.A, the level of surface-exposed EGFR in the indicated cell lines was measured before (-) and after (+) EGF (50 ng/ml) was added to serum-starved cells for 30 min at 37 degreesC. Treated cells were then surface-labeled with biotin (30 min, 23 degreesC), and EGFR proteins were recovered by IP and Western blotted (WB) with FLAG antibodies to reveal total EGFR-FLAG (lower panel) and with a horseradish peroxidase-streptavidin conjugate to identify biotin-labeled receptors (upper panel). B, fluorescence-activated cell sorting analysis was used to quantify the time course of internalization of rhodamine-EGF by cells expressing the indicated WT and variant EGFR proteins. Both variant proteins were statistically different from WT (*, p = 0.05; **, p = 0.01). Error bars indicate S.D. from four independent experiments.
###end p 43
###begin title 44
EGFR-associated Proteins and Phosphorylation
###end title 44
###begin p 45
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 101 104 101 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
To further address the function of the kinase domain proximal phosphorylation sites at Ser991 and Tyr998, receptor-associated proteins and receptor phosphorylation were examined by using LC-MS/MS and in some instances quantified by SRM. Tandem MS analysis served three purposes. First, it enabled the identification of receptor-associated proteins, which could then be compared with a reference set of EGFR-associated proteins. Second, it facilitated the measurement of spectral counts as a first approximation of protein abundance (39). Third, it provided information on peptides and their fragmentations, which were useful in the design of SRM methods for the quantification of receptor-associated proteins in repeated experiments.
###end p 45
###begin p 46
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 487 491 487 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 601 603 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 718 720 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 961 968 961 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="TI">Table I</xref>
###xml 1256 1263 1256 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="TI">Table I</xref>
###xml 836 841 <span type="species:ncbi:9606">Human</span>
EGFR immunoprecipitates from EGF-stimulated cells expressing WT and variant EGFR proteins were prepared by using anti-FLAG antibodies and analyzed by LC-MS/MS for associated proteins similar to previously published methods involving gel-free, LC-MS/MS analysis of trypsin-digested, anti-FLAG immunoprecipitates (22, 40). In aggregate 444 proteins were identified in the anti-FLAG immunoprecipitates of WT and mutant receptors by using criteria described under "Experimental Procedures" (i.e. at least two distinct peptides and 95% probability scores by Peptide Prophet and Protein Prophet algorithms (27, 28)). Not surprisingly, this list () contains proteins commonly known to associate with FLAG immunoprecipitates (40). To focus the analysis of receptor-associated proteins, the list was compared with data from the manually curated Human Protein Reference Database, which lists 144 EGFR-binding proteins that have experimental validation in the literature. Table I shows the 17 proteins, in addition to the EGFR, that intersect these two data sets including the ligand EGF; proteins involved in EGFR signaling such as SHC1, GRB2, and SOS1; and others associated with receptor endocytosis, including the ubiquitin E3 ligases CBL and CBLB and ubiquitin (Table I).
###end p 46
###begin title 47
EGFR-associated proteins
###end title 47
###begin p 48
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
Proteins identified in EGFR immunoprecipitates are listed according to their IPI number, protein name, and molecular weight as indicated. Percent sequence coverage and protein identification probability according to the Protein Prophet algorithm (29) are also shown. LC-MS/MS analysis (LTQ-Orbitrap) was performed with trypsin-digested EGFR immunoprecipitates from unstimulated WT EGFR-expressing cells (Cont) and EGF-stimulated cells expressing WT EGFR (EGFR), Y988F variant (Y988F), and S991A variant (S991A). Spectral counts (columns 6-9) are the total number of spectra, including repeat identifications, of peptides derived from the indicated proteins. The spectral counts in each column were normalized by a factor such that the number of unphosphorylated EGFR-derived peptides (shown in the top row) were equalized to the value obtained for the EGFR sample. The actual number of non-phosphorylated, receptor-derived peptides is shown in parentheses. Note that the accession number for EGF corresponds to the 1207-residue pre/pro-EGF protein, whereas the degree of coverage, corresponding to residues 971-1011, relates to overlap within the 53-residue, processed growth factor (residues 971-1023).
###end p 48
###begin p 49
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>a</italic></sup>
a Normalized to EGF-stimulated WT EGFR.
###end p 49
###begin p 50
###xml 331 338 331 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="TI">Table I</xref>
###xml 825 832 825 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="TI">Table I</xref>
The spectral counts of these EGFR-associated proteins were noted as a crude measure of their abundance in the IP samples. Spectral counts were normalized by adjusting for the number of spectral counts from non-phosphorylated EGFR peptides. EGFR peptides, as expected, were by far the most abundant class of peptide in the samples (Table I), and this observation served to validate that the IP method was specific for this antigen. For each of the proteins mentioned above, VAV2, and the phosphatidylinositol 3-kinase p85 subunits (PIK3R1 and PIK3R2), spectral counts associated with WT EGFR increased as a consequence of EGF treatment of cells. Furthermore with the exception of EGF and CBLB, the spectral counts for these proteins measured with EGF-stimulated Y998F and S991A receptors were less than those observed for WT (Table I).
###end p 50
###begin p 51
###xml 382 389 382 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="TI">Table I</xref>
###xml 924 928 924 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 955 956 951 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 957 958 953 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 1298 1304 1294 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 1309 1317 1305 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="TII">Table II</xref>
To quantify the receptor-associated proteins, including changes due to EGF stimulation and as a consequence of the Y998F and S991A mutations, SRM analysis was applied to the receptor.immunoprecipitate complexes isolated from cells before and after EGF treatment. An SRM method that tracked the top six EGFR-associated proteins (according to spectral counts associated with WT EGFR; Table I) was formulated based on transitions summarized in . The fragmentation patterns obtained during discovery analyses with the LTQ-Orbitrap were a useful starting point toward the development of the SRM transitions. However, the resonance excitation-based fragmentations produced in the linear ion trap were not identical with the true CIDs undertaken in Q2 of the triple quadrupole TSQ instrument that was used for SRM. The intensity of b ions was generally greater in the linear ion trap, which also had a low molecular weight cutoff (i.e. (1/3) rule) that made low m/z ions more predominant in the triple quadrupole TSQ instrument. In addition, the LC gradients were of different durations (120 min with the Orbitrap and 40 min with the TSQ instrument). The SRM method was applied in three independent biological experiments resulting in the quantification the EGFR and the six receptor-associated proteins (Fig. 5 and Table II). The EGFR peptide YSFGATCVK (residues 285-293; described above), which is common to the WT and variant proteins and not subject to phosphorylation, was quantified and used to normalize for the amount of EGFR in each sample.
###end p 51
###begin title 52
SRM-based measurement of six EGFR-associated proteins
###end title 52
###begin p 53
###xml 408 409 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 410 411 404 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 660 661 654 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 752 758 746 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
Cells stably expressing FLAG-tagged wild type receptor (EGFR) or the S991A and Y998F EGFR proteins (as indicated) were treated with or without EGF (100 ng/ml) for 15 min at 37 degreesC. Anti-FLAG immune complexes were digested with trypsin and analyzed by SRM ("Experimental Procedures"). Protein name and peptide sequence are indicated in the first two columns, respectively. The third column indicates the m/z values for the Q1-to-Q3 transitions that were monitored. In columns 4-12, the EGF-induced -fold change in abundance of associated proteins is indicated for the WT EGFR and the indicated variant receptors. -Fold changes are presented as the mean of n = 3 independent experiments with CV and S.E. and correspond to the histogram presented in Fig. 5.
###end p 53
###begin p 54
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SRM-based measurement of EGFR-associated proteins.</bold>
###xml 353 361 353 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="TII">Table II</xref>
###xml 608 609 606 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 689 693 687 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 806 807 804 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 827 847 825 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Asterisks above bars</italic>
###xml 979 980 977 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 993 994 991 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1008 1009 1006 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1190 1191 1188 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1228 1231 1226 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UBB</italic>
###xml 1253 1265 1251 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dashed lines</italic>
SRM-based measurement of EGFR-associated proteins. EGFR was recovered by anti-FLAG IP from HEK cells stably expressing WT EGFR or one of the variants Y998F or S991A. The immune complexes were converted to tryptic peptides, which were subjected to SRM analysis to specifically monitor transitions derived from the indicated EGFR-associated proteins (see Table II). Protein amounts are expressed per unit of EGFR protein after normalization with an intrinsic EGFR peptide (see "Experimental Procedures"). Protein amounts are shown as EGF-induced -fold increases relative to unstimulated cells (means +/- S.E., n = 3). For the purpose of constructing the histogram, values from unstimulated (i.e. no EGF) cells were set to unity; however, variation associated with all measurements were included in Student's t test calculations. Asterisks above bars indicate statistically significant differences from the amount of receptor-associated protein measured with unstimulated cells (*, p = 0.05; **, p = 0.01; ***, p = 0.005). Additionally the level of receptor association achieved by each of the proteins in EGF-stimulated cells was compared and found to be statistically different from WT (**, p = 0.01) only for CBL and ubiquitin (UBB) as indicated by the dashed lines.
###end p 54
###begin p 55
###xml 72 78 72 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 452 453 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 462 468 450 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 711 717 699 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 982 988 970 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 1454 1460 1442 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 1463 1471 1451 1459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="TII">Table II</xref>
###xml 1575 1581 1563 1569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
The interactions of all six proteins were verified by the SRM analysis (Fig. 5). The largest EGF-stimulated -fold increases in receptor binding were observed for CBL followed by GRB2. CBL association with WT EGFR increased more than 7-fold following EGF treatment but was less than 5-fold with S991A and was approximately4-fold with the Y998F variant. The drop in CBL association associated with the Y998F mutation was significantly different from WT (p = 0.01; Fig. 5). EGF-stimulated receptor association of GRB2 was roughly 3-fold, which was a statistically significant increase over that observed without EGF treatment, and the measurements for GRB2 were not different between WT and the variant receptors (Fig. 5). The associations of VAV2 and SOS1 were measured to be essentially constitutive and unaffected by the phosphorylation site mutations because no statistically significant differences were noted following EGF treatments or between the WT and the variant receptors (Fig. 5). The binding of SHC1 to WT EGFR was stimulated more than 2-fold by EGF, but for the receptor variants, EGF-stimulated SHC1 association was associated with too much variation to be considered significant. The capture of ubiquitin with WT and Y998F was increased more than 3-fold by EGF but to a lesser extent with the S991A variant. Furthermore with EGF-treated cells the amount of receptor-associated ubiquitin was significantly reduced in S991A compared with WT (Fig. 5). Table II shows the peptides, SRM transitions, and coefficients of variance associated with the data depicted in Fig. 5. A more complete listing of these measurements including SRM intensities for each of the three repeated experiments is provided in .
###end p 55
###begin p 56
###xml 103 109 103 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 212 216 212 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1069</sup>
###xml 346 352 346 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
The observed changes in receptor-associated CBL and ubiquitin were supported by Western blot analysis (Fig. 6). The variant receptors were not generally impaired for phosphorylation at the CBL binding site Ser(P)1069, but the Y998F and S991A protein complexes captured by anti-FLAG IP were observed to contain less CBL and ubiquitin than did WT (Fig. 6). The co-immunoprecipitation of ubiquitin may reflect the ubiquitination of any of the proteins in the receptor (anti-FLAG) immunoprecipitates. However, prominent anti-ubiquitin immunostaining was concentrated at or slightly above the migration of the receptors, suggesting that ubiquitination of the receptors, as expected (19), may account for a portion of the ubiquitin measured by MS.
###end p 56
###begin p 57
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Western blot analysis of EGFR and associated proteins.</bold>
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 406 407 400 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 415 416 409 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 434 436 428 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ub</italic>
###xml 438 439 432 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 501 502 495 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 563 567 557 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1069</sup>
###xml 569 570 563 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 633 635 627 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WB</italic>
###xml 651 653 645 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pY</italic>
Western blot analysis of EGFR and associated proteins. FLAG-tagged wild type receptor (EGFR) and the variants Y998F and S991A, as indicated, were collected by anti-FLAG IP from total cell lysates prepared from cells treated without or with EGF (15 min, 37 degreesC, 100 ng/ml; see "Experimental Procedures"). Following SDS-PAGE and electrophoretic transfer, filters were developed with antibodies to FLAG (A), CBL (B), and ubiquitin (Ub; C). A portion of the lysates was analyzed without IP for FLAG (D) and the CBL binding site at phosphorylated EGFR residue Tyr1069 (E). Shown are representative results from repeated experiments. WB, Western blot; pY, phosphotyrosine.
###end p 57
###begin p 58
###xml 60 62 60 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
The level of endogenous EGFR in HEK293 cells is very minor (22), and association with other ErbB family receptors was not detected. This indicated that dimerization of FLAG-tagged ectopic receptors with endogenous ErbB family members to which associated proteins might bind was not a factor in these experiments.
###end p 58
###begin p 59
###xml 436 445 436 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="TIII">Table III</xref>
Among the peptides characterized by LC-MS/MS analysis of EGFR immunoprecipitates were phosphopeptides. Following EGF stimulation, the total number of spectral counts for EGFR-derived phosphorylated peptides was 69 for WT EGFR, 72 for the Y998F variant, and 73 for S991A. Thus, by this estimation the mutants missing one or another kinase domain proximal phosphorylation site were not generally impaired for phosphorylation. As shown in Table III, there is evidence for phosphorylation at 18 sites on the receptor, including three Thr(P), six Tyr(P), and nine Ser(P). Additional information related to these assignments including protein search algorithm scores and MS/MS spectra are included in  and . The low number of observed phosphopeptides was not surprising because no phosphopeptide enrichment was used in this analysis. For several sites, the number of observed spectra was too low to warrant further discussion.
###end p 59
###begin title 60
###xml 115 119 115 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 127 131 127 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
EGFR phosphorylation site analysis suggests increased levels of EGF-induced phosphorylation compared with WT at Ser1039 and Thr1041 in the Y998F and S991A variants
###end title 60
###begin p 61
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 558 562 558 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 573 577 573 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
The indicated FLAG-tagged receptor proteins were recovered by IP from unstimulated WT EGFR-expressing cells (Cont) and EGF-stimulated cells expressing WT EGFR (EGFR), Y988F variant (Y988F), and S991A variant (S991A). The immune complexes were digested with trypsin, and peptides were analyzed by LC-MS/MS. Total spectral counts, peptide sequences, and phosphosites are indicated. The bold area includes a Ser/Thr-rich region spanning 1026-1046 previously implicated to contain p38 MAP kinase phosphorylation sites (18) and includes peptides containing Ser(P)1039 and Thr(P)1041. pS, phosphoserine; pT, phosphothreonine; pY, phosphotyrosine.
###end p 61
###begin p 62
###xml 163 172 163 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="TIII">Table III</xref>
###xml 318 327 318 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="TIII">Table III</xref>
###xml 381 385 381 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
###xml 404 408 404 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 488 497 488 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="TIII">Table III</xref>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 729 733 729 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 744 748 744 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
Surprisingly in the region spanning EGFR residues 1000-1052 there was evidence for increased phosphorylation with the Y998F and S991A variants (see bold region in Table III). There were, respectively, 20 and 23 phosphorylated peptides identified by spectral counting for these variants but only six in the case of WT (Table III). Most notable were phosphorylations at positions Thr1041 and especially Ser1039 for which spectral counts were higher in the two receptor variants than in WT (Table III). Both of these phosphorylations were observed previously in EGF-stimulated HeLa cells (10). These sites reside in the same tryptic peptide spanning residues 1032-1052. This peptide was also detected doubly phosphorylated at Ser(P)1039 and Ser(P)1041, but the ion current intensities were relatively low (data not shown).
###end p 62
###begin p 63
###xml 64 68 64 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 78 82 78 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
###xml 207 213 207 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 215 216 215 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 221 222 221 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 387 393 387 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 393 394 393 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 649 653 649 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 785 791 785 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 793 794 793 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 796 797 796 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 803 804 803 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 895 901 895 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 903 904 903 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 909 910 909 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1068 1074 1068 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 1084 1085 1084 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1090 1091 1090 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1166 1170 1166 1170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 1228 1232 1228 1232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
The monophosphorylated isobaric isomers containing either Ser(P)1039 or Thr(P)1041 were analyzed by LC-MS/MS, which confirmed their identities. For example, their y12 fragment ions were clearly distinctive (Fig. 7, A and B). The two species did not co-elute during reverse phase chromatography, and this facilitated their resolution and ion current measurement by high resolution LC-MS (Fig. 7C). To facilitate the quantification of these species by SRM, the measurement of transitions involving distinctive y ions was attempted but proved inefficient. Therefore, an optimized SRM method was developed that included neutral loss of phosphoric acid (i.e. doubly charged parent - 98/2) and y5-associated transitions, which were common to the two phosphoisomers and efficiently detected (Fig. 7, A, B, and D). Note that different elution gradients were used for the LC-MS and SRM analyses shown in Fig. 7, C and D, respectively, so the retention times were not identical. The Orbitrap MS extracted ion current chromatograph and triple quadrupole SRM traces were similar (Fig. 7, compare C and D), and several repeats of the LC-MS/MS experiment indicated that the Ser(P)1039 peptide consistently eluted immediately before the Thr(P)1041 isomer.
###end p 63
###begin p 64
###xml 59 63 59 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 71 75 71 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
###xml 0 96 0 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Detection and quantification of phosphorylation at EGFR Ser<sup>1039</sup> and Thr<sup>1041</sup> by LC-MS/MS and SRM.</bold>
###xml 96 97 96 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 102 103 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 250 254 250 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 297 298 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 315 319 315 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
###xml 363 364 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 416 422 416 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arrows</italic>
###xml 466 467 466 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 468 469 468 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 517 521 517 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 523 524 523 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 536 540 536 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
###xml 542 543 542 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 565 569 565 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
###xml 579 583 579 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
###xml 631 632 631 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 689 690 689 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 691 692 691 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 802 803 802 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 949 950 949 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 951 952 951 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 964 965 964 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 1009 1010 1009 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 1011 1012 1011 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 1024 1025 1024 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 1042 1043 1042 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 1044 1045 1044 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 1056 1057 1056 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 1077 1078 1077 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 1083 1084 1083 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1154 1158 1154 1158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 1168 1169 1168 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 1181 1185 1181 1185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
###xml 1195 1196 1195 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1346 1353 1346 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Control</italic>
###xml 1365 1368 1365 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGF</italic>
###xml 1486 1487 1479 1480 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1491 1494 1484 1487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGF</italic>
###xml 1495 1497 1488 1490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SB</italic>
###xml 1500 1510 1493 1503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Error bars</italic>
###xml 1686 1689 1679 1682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGF</italic>
###xml 1755 1758 1748 1751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGF</italic>
###xml 1759 1761 1752 1754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SB</italic>
###xml 1821 1824 1814 1817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGF</italic>
###xml 1830 1831 1823 1824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1942 1943 1935 1936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 2030 2033 2023 2026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XIC</italic>
Detection and quantification of phosphorylation at EGFR Ser1039 and Thr1041 by LC-MS/MS and SRM.A and B, trypsin-digested immuno (anti-FLAG) purified EGFR proteins were analyzed by high resolution LC-MS/MS. MS/MS spectra of the EGFR peptide TPLLSSLpS1039ATSNNSTVACIDR (where pS is phosphoserine) (A) and TPLLSSLSApT1041SNNSTVACIDR (where pT is phosphothreonine) (B) are shown. The y and b series ions are indicated. Arrows point to product y12 ions. As expected the m/z values of y12 ions are different between Ser(P)1039 (A) and Thr(P)1041 (B) peptides because Thr1041 or Thr(P)1041 is the amino-terminal residue in the y12 ions. C, the orbitrap XIC for the isobaric phosphopeptides with m/z 1144.04 and containing Ser(P)1039 or Thr(P)1041, as indicated, are shown to be chromatographically resolved. D, SRM LC elution profiles plotting the summed signal intensities of ions corresponding to singly phosphorylated TPLLSSLSATSNNSTVACIDR (precursor, m/z = 1144.04, z = 2) transitioning to 1) precursor - 98/2 (m/z = 1095.05, z = 2) and 2) y5 (m/z = 634.30, z = 1) as indicated. E and F, histograms depicting the integrated SRM signal intensities of Ser(P)1039 peptide (E) and Thr(P)1041 peptide (F) normalized to a control EGFR peptide in the same sample (see "Experimental Procedures"). EGFR, Y998F, and S991A cell cultures were treated without (Control) or with (+EGF) EGF (100 ng/ml, 15 min, 37 degreesC) or with EGF after a 30-min pretreatment with the p38 inhibitor SB-202190 (10 mum) (+EGF+SB). Error bars indicate S.D. from three biological repeats of the experiment. For statistical analysis, Y998F and S991A samples were compared with wild type EGFR in EGF-stimulated samples (+EGF), and EGFR, Y998F and S991A samples in SB-202190 treated cells (+EGF+SB) were compared with themselves in EGF-stimulated samples (+EGF). *, p = 0.05 compared with wild type EGFR +EGF. In all cases phosphopeptides were statistically significantly less (p = 0.05) for control and SB-202190-treated samples compared with cognate +EGF samples. XIC, extracted ion current.
###end p 64
###begin p 65
###xml 84 88 84 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 96 100 96 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
###xml 386 395 386 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="TIII">Table III</xref>
###xml 477 481 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 642 646 638 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 692 694 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 697 703 693 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 705 706 701 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 711 712 707 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 910 914 894 898 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 943 949 925 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 949 950 931 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 1060 1064 1042 1046 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 1142 1146 1124 1128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 1266 1268 1241 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1344 1350 1319 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 1350 1351 1325 1326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 1398 1402 1373 1377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
###xml 1442 1446 1417 1421 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
###xml 1538 1544 1511 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 1544 1545 1517 1518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1555 1559 1528 1532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
###xml 1616 1622 1589 1595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 1622 1623 1595 1596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
Having established the SRM method, it was applied to quantify phosphorylation at Ser1039 and Thr1041 and address three questions: first, to determine whether these modifications were affected by EGF ligand; second, to determine whether they were elevated with the Y998F and S991A variant receptors compared with WT as implied by the semiquantitative spectral counting analysis shown in Table III; and third, to determine whether these modifications require p38 kinase. Stress (e.g. TNFalpha or UV irradiation)-induced p38 kinase-dependent phosphorylation within the Ser/Thr-rich segment of the EGFR spanning residues 1026-1046, but not at Ser1039 specifically, was shown by Zwang and Yarden (17). Fig. 7, E and F, present a summary of three independent repeats of an experiment that addressed these questions. Stimulation of cells with EGF caused an approximately3-fold elevation in the abundance of the Ser(P)1039 peptide (3.4 +/- 1.3 S.D.) (Fig. 7E), whereas both the Y998F and S991A variants showed a roughly 10-fold elevation in the abundance of the Ser(P)1039 peptide after EGF treatment. The pronounced EGF-stimulated increase in Ser(P)1039 was largely eliminated by treatment of cells with SB-202190, which is a potent inhibitor of MAP kinases p38alpha/beta (23), indicating that these phosphorylation sites are regulated by p38 kinase (Fig. 7E). A similar phenomenon was observed for Thr(P)1041 wherein EGF treatment stimulated Tyr(P)1041 more than 2-fold in WT (2.7 +/- 1.1 S.D.) but to an even greater extent with the variants (Fig. 7F). The Thr1041 modifications were also sensitive to the p38 inhibitor (Fig. 7F).
###end p 65
###begin title 66
DISCUSSION
###end title 66
###begin title 67

###end title 67
###begin title 68

###end title 68
###begin title 69
EGFR Mutants Y998F and S991A Signal to ERK but Are Defective in Endocytosis
###end title 69
###begin p 70
###xml 239 240 239 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 242 243 242 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 285 288 285 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 296 299 296 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
Cellular responses to EGFR activation occur with different kinetics, and to some extent this reflects temporal regulation of receptor and substrate phosphorylation and the dynamics of receptor trafficking and protein-protein interactions (3, 9, 10). The phosphorylations of EGFR at Ser991 and Tyr998 were found in tumors as sites modulated by EGF and an EGFR kinase inhibitor, suggesting their involvement in EGFR regulation and/or signaling (10, 12). In this study and other published reports (10) EGF-stimulated phosphorylations at these sites occurred with relatively slow kinetics and in this study were found not to be required for downstream ERK activation, which suggests that their function is not required for signaling along the RAS-ERK axis. Indeed the results from three different assays indicated that the phosphorylation-deficient variants S991A and Y998F were defective in receptor endocytosis. These data indicate that to some extent signaling may proceed independently of normal receptor trafficking.
###end p 70
###begin p 71
###xml 101 104 101 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 136 139 136 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 148 154 148 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 173 176 173 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 397 400 396 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 408 412 407 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1001</sup>
###xml 479 482 478 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 663 666 661 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 830 832 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 997 999 995 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
Our data indicate that EGFR endocytosis is subject to regulation involving the phosphorylation of Tyr998 and amino-terminal to it at Ser991. Sorkin et al. (16) described Tyr998 as part of a tyrosine-based internalization motif. Indeed the structural analysis by Owen and Evans (41) of an EGFR peptide containing this residue (FYRALM) bound to the endocytosis adaptor protein adaptin mu2 showed Tyr998 and Leu1001 tightly bound in pockets and predicted that phosphorylation at Tyr998, which was not yet appreciated, would prevent the receptor-mu2 interaction. The cell adhesion molecule L1 contains a tyrosine-based endocytosis motif (YRSL) similar to the EGFR Tyr998 motif (YRAL). In L1, tyrosine phosphorylation of the motif appears to modulate L1 interactions with adaptin AP-2 as a requisite for clathrin-mediated endocytosis (42). We did not identify adaptins as EGFR-associated likely because our buffers lacked deoxycholate as a reagent necessary for the detection of the EGFR.AP-2 complex (16). A more detailed analysis of the subcellular localization of Y998F and S991A receptor variants may provide more insight into the function of the 998 and 991 phosphorylation sites and mechanisms of EGFR trafficking.
###end p 71
###begin p 72
###xml 30 33 30 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 41 44 41 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 83 86 83 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 124 130 124 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 214 220 214 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 710 713 710 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 759 762 759 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 764 766 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 882 885 882 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 893 896 893 896 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 974 976 974 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1002 1005 1002 1005 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 1070 1073 1070 1073 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 1162 1164 1162 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
Given the slow kinetics of Tyr998 and Ser991 phosphorylation, in the case of Ser(P)991 still accumulating 90 min after EGF (Fig. 1), it is possible these modifications are not required for receptor internalization per se but may play a role at a later stage of endocytosis. For example, phosphorylation at these sites may promote dissociation of proteins from internalized receptors that would otherwise impair subsequent trafficking. Our findings do not indicate the full nature of the receptor endocytosis defect associated with the variant receptors nor the extent to which this phenotype is a consequence of the side chain substitutions or their lack of phosphorylation but clearly establish a role for Ser991, in addition to the known requirement for Tyr998 (16), in EGFR endocytosis. This study did not aim to identify the kinase(s) responsible for the phosphorylations at Tyr998 and Ser991. Given evidence that EGFR endocytosis does not require EGFR kinase activity (26), we predict that the Tyr998 kinase is not the EGFR itself. Again this is consistent with Tyr998 phosphorylation accumulating after the initial wave of EGFR autophosphorylation events (10).
###end p 72
###begin title 73
Quantification of EGFR-associated Proteins and Phosphorylation by SRM
###end title 73
###begin p 74
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 514 516 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 516 516 516 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44"/>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 730 734 730 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1069</sup>
###xml 833 835 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 837 839 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 839 839 839 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47"/>
###xml 839 839 839 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48"/>
###xml 840 842 840 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 961 963 961 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 1083 1087 1083 1087 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1092</sup>
###xml 1089 1091 1089 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
The results obtained by SRM-based examination of a limited set of receptor-associated proteins are consistent with the conclusion that the S991A and Y998F variants are defective in EGFR endocytosis. Among the six well established EGFR-associated proteins examined, the ubiquitin E3 ligase CBL and ubiquitin itself were found to differ from WT with one or the other endocytosis-defective receptor variant. Ubiquitin and CBL have defined roles in the down-regulation of EGFR and other receptor tyrosine kinases (19, 43-45). Western blot analysis confirmed the diminished association of CBL with the activated variant receptors compared with WT and demonstrated that the mutant receptors remained competent for phosphorylation at Tyr1069, which is the direct binding site on the receptor for CBL. GRB2 is required for EGFR endocytosis (24, 46-49). In addition, it interacts with SHC and SOS1/2 as effectors of RAS and ERK downstream of activated tyrosine kinases (50). The EGFR variants Y998F and S991A retained both EGF-stimulated phosphorylation at the principal GRB2 binding site Tyr1092 (38) and GRB2 association in amounts not significantly different from WT. This further indicates that the early stages of ligand-stimulated receptor activation were not impaired by the Y998F and S991A mutations and that the endocytosis defects associated with Y998F and S991A are not a consequence of impaired GRB2 bindings to the receptors.
###end p 74
###begin p 75
The EGF-stimulated increase in receptor-associated ubiquitin displayed by the variant receptors (although for S991A it was less than that of WT) is consistent with the conclusion that to some extent they did become internalized. However, our data do not address which proteins in the receptor complexes were covalently modified by ubiquitin.
###end p 75
###begin title 76
A Link between EGFR Recycling and Degradation Pathways
###end title 76
###begin p 77
###xml 155 159 155 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 167 171 167 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
###xml 262 266 262 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 274 278 274 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
###xml 850 852 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1028 1030 1024 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1088 1091 1084 1087 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 1099 1102 1095 1098 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 1215 1219 1211 1215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 1227 1231 1223 1227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
###xml 1461 1465 1457 1461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
Our data revealed an unforeseen connection between the pathways of EGFR recycling and down-regulation. The p38 MAP kinase-dependent phosphorylations at Ser1039 and Thr1041 in the endocytosis-defective variants were pronounced. Because the phosphorylations at Ser1039 and Thr1041 were EGF-stimulated, we conclude they are a normal part of the EGF response and that the Y998F and S991A mutations do not themselves constitute a "stress" that induced the recycling response in cells. Unmapped p38-dependent phosphorylation(s) in a 21-residue segment of the receptor (spanning 1026-1046) that includes these residues was shown previously to be required for EGFR recycling following cell treatments including TNFalpha, osmotic stress, UV irradiation, and the chemotherapeutic agent cisplatinum but was not linked to EGF ligand-stimulated EGFR endocytosis (17). Indeed p38 kinase is not required for EGF-stimulated EGFR internalization but is required subsequently for CBL-mediated ubiquitination and degradation of internalized EGFR (21). We speculate that the phosphorylations at positions Ser991 and Tyr998 that accompany EGFR activation by ligand are normally involved in dampening the levels of phosphorylation at Ser1039 and Thr1041 as part of a mechanism to prevent receptor recycling and promote receptor destruction. In this model, the endocytosis defects associated with the S991A and Y998F variants may be due in part to inappropriate phosphorylation at Ser1039 and consequently uncoordinated trafficking of internalized receptors.
###end p 77
###begin p 78
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">991</sup>
###xml 54 57 54 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">998</sup>
###xml 210 214 210 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1039</sup>
###xml 222 226 222 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1041</sup>
###xml 515 516 515 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
In conclusion, our results identify the Ser991 and Tyr998 phosphorylation sites as important determinants in ligand-stimulated EGFR endocytosis linked to p38 MAP kinase-dependent receptor phosphorylation at Ser1039 and Thr1041. A better understanding of the mechanism by which these receptor phosphorylations are regulated and coordinated may reveal further insight into the molecular mechanisms that govern receptor recycling and degradation, which are important determinants in EGFR-directed cancer therapeutics (3, 51).
###end p 78
###begin title 79
Supplementary Material
###end title 79
###begin title 80
[Supplemental Data]
###end title 80
###begin p 81
We thank Jonathan St-Germain for comments on the manuscript.
###end p 81
###begin p 82
* This work was supported by funding from the Canadian Cancer Society Research Institute, Canadian Institutes of Health Research, Canada Research Chairs Program, and The McLaughlin Centre for Molecular Medicine (to M. F. M.).
###end p 82
###begin p 83
###xml 0 0 0 0 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="sbox.jpg"/>
###xml 0 0 0 0 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><inline-graphic xlink:href="sbox.jpg"/></sup>
 The on-line version of this article (available at ) contains .
###end p 83
###begin p 84
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
2 The convention for EGFR numbering includes the 24-residue signal sequence.
###end p 84
###begin p 85
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
1 The abbreviations used are:
###end p 85
###begin p 86
###xml 0 4 0 4 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</term>
###xml 4 36 4 36 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="87">epidermal growth factor receptor</p>
###xml 4 36 4 36 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="87">epidermal growth factor receptor</p></def>
###xml 0 36 0 36 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>EGFR</term><def><p textid="87">epidermal growth factor receptor</p></def></def-item>
###xml 36 39 36 39 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGF</term>
###xml 39 62 39 62 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="88">epidermal growth factor</p>
###xml 39 62 39 62 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="88">epidermal growth factor</p></def>
###xml 36 62 36 62 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>EGF</term><def><p textid="88">epidermal growth factor</p></def></def-item>
###xml 62 65 62 65 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ERK</term>
###xml 65 102 65 102 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="89">extracellular signal-regulated kinase</p>
###xml 65 102 65 102 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="89">extracellular signal-regulated kinase</p></def>
###xml 62 102 62 102 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>ERK</term><def><p textid="89">extracellular signal-regulated kinase</p></def></def-item>
###xml 102 105 102 105 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SRM</term>
###xml 105 133 105 133 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="90">selected reaction monitoring</p>
###xml 105 133 105 133 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="90">selected reaction monitoring</p></def>
###xml 102 133 102 133 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>SRM</term><def><p textid="90">selected reaction monitoring</p></def></def-item>
###xml 133 136 133 136 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAP</term>
###xml 136 161 136 161 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="91">mitogen-activated protein</p>
###xml 136 161 136 161 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="91">mitogen-activated protein</p></def>
###xml 133 161 133 161 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>MAP</term><def><p textid="91">mitogen-activated protein</p></def></def-item>
###xml 161 164 161 164 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF</term>
###xml 164 185 164 185 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="92">tumor necrosis factor</p>
###xml 164 185 164 185 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="92">tumor necrosis factor</p></def>
###xml 161 185 161 185 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>TNF</term><def><p textid="92">tumor necrosis factor</p></def></def-item>
###xml 185 187 185 187 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E3</term>
###xml 187 222 187 222 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="93">ubiquitin-protein isopeptide ligase</p>
###xml 187 222 187 222 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="93">ubiquitin-protein isopeptide ligase</p></def>
###xml 185 222 185 222 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>E3</term><def><p textid="93">ubiquitin-protein isopeptide ligase</p></def></def-item>
###xml 222 225 222 225 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GFP</term>
###xml 225 250 225 250 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="94">green fluorescent protein</p>
###xml 225 250 225 250 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="94">green fluorescent protein</p></def>
###xml 222 250 222 250 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>GFP</term><def><p textid="94">green fluorescent protein</p></def></def-item>
###xml 250 252 250 252 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IP</term>
###xml 252 271 252 271 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="95">immunoprecipitation</p>
###xml 252 271 252 271 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="95">immunoprecipitation</p></def>
###xml 250 271 250 271 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>IP</term><def><p textid="95">immunoprecipitation</p></def></def-item>
###xml 271 277 271 277 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HEK293</term>
###xml 277 303 277 303 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="96">human embryonic kidney 293</p>
###xml 277 303 277 303 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="96">human embryonic kidney 293</p></def>
###xml 271 303 271 303 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>HEK293</term><def><p textid="96">human embryonic kidney 293</p></def></def-item>
###xml 303 306 303 306 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NHS</term>
###xml 306 307 306 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 306 326 306 326 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="97"><italic>N</italic>-hydroxysuccinimide</p>
###xml 306 326 306 326 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="97"><italic>N</italic>-hydroxysuccinimide</p></def>
###xml 303 326 303 326 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>NHS</term><def><p textid="97"><italic>N</italic>-hydroxysuccinimide</p></def></def-item>
###xml 326 329 326 329 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSQ</term>
###xml 329 352 329 352 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="98">triple stage quadrupole</p>
###xml 329 352 329 352 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="98">triple stage quadrupole</p></def>
###xml 326 352 326 352 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>TSQ</term><def><p textid="98">triple stage quadrupole</p></def></def-item>
###xml 352 354 352 354 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CV</term>
###xml 354 378 354 378 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="99">coefficient of variation</p>
###xml 354 378 354 378 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="99">coefficient of variation</p></def>
###xml 352 378 352 378 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>CV</term><def><p textid="99">coefficient of variation</p></def></def-item>
###xml 378 380 378 380 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</term>
###xml 380 389 380 389 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="100">wild type</p>
###xml 380 389 380 389 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="100">wild type</p></def>
###xml 378 389 378 389 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>WT</term><def><p textid="100">wild type</p></def></def-item>
###xml 389 392 389 392 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPI</term>
###xml 392 420 392 420 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="101">International Protein Index.</p>
###xml 392 420 392 420 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="101">International Protein Index.</p></def>
###xml 389 420 389 420 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>IPI</term><def><p textid="101">International Protein Index.</p></def></def-item>
###xml 0 420 0 420 <def-list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><def-item><term>EGFR</term><def><p textid="87">epidermal growth factor receptor</p></def></def-item><def-item><term>EGF</term><def><p textid="88">epidermal growth factor</p></def></def-item><def-item><term>ERK</term><def><p textid="89">extracellular signal-regulated kinase</p></def></def-item><def-item><term>SRM</term><def><p textid="90">selected reaction monitoring</p></def></def-item><def-item><term>MAP</term><def><p textid="91">mitogen-activated protein</p></def></def-item><def-item><term>TNF</term><def><p textid="92">tumor necrosis factor</p></def></def-item><def-item><term>E3</term><def><p textid="93">ubiquitin-protein isopeptide ligase</p></def></def-item><def-item><term>GFP</term><def><p textid="94">green fluorescent protein</p></def></def-item><def-item><term>IP</term><def><p textid="95">immunoprecipitation</p></def></def-item><def-item><term>HEK293</term><def><p textid="96">human embryonic kidney 293</p></def></def-item><def-item><term>NHS</term><def><p textid="97"><italic>N</italic>-hydroxysuccinimide</p></def></def-item><def-item><term>TSQ</term><def><p textid="98">triple stage quadrupole</p></def></def-item><def-item><term>CV</term><def><p textid="99">coefficient of variation</p></def></def-item><def-item><term>WT</term><def><p textid="100">wild type</p></def></def-item><def-item><term>IPI</term><def><p textid="101">International Protein Index.</p></def></def-item></def-list>
EGFRepidermal growth factor receptorEGFepidermal growth factorERKextracellular signal-regulated kinaseSRMselected reaction monitoringMAPmitogen-activated proteinTNFtumor necrosis factorE3ubiquitin-protein isopeptide ligaseGFPgreen fluorescent proteinIPimmunoprecipitationHEK293human embryonic kidney 293NHSN-hydroxysuccinimideTSQtriple stage quadrupoleCVcoefficient of variationWTwild typeIPIInternational Protein Index.
###end p 86
###begin p 87
epidermal growth factor receptor
###end p 87
###begin p 88
epidermal growth factor
###end p 88
###begin p 89
extracellular signal-regulated kinase
###end p 89
###begin p 90
selected reaction monitoring
###end p 90
###begin p 91
mitogen-activated protein
###end p 91
###begin p 92
tumor necrosis factor
###end p 92
###begin p 93
ubiquitin-protein isopeptide ligase
###end p 93
###begin p 94
green fluorescent protein
###end p 94
###begin p 95
immunoprecipitation
###end p 95
###begin p 96
###xml 0 5 <span type="species:ncbi:9606">human</span>
human embryonic kidney 293
###end p 96
###begin p 97
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
N-hydroxysuccinimide
###end p 97
###begin p 98
triple stage quadrupole
###end p 98
###begin p 99
coefficient of variation
###end p 99
###begin p 100
wild type
###end p 100
###begin p 101
International Protein Index.
###end p 101
###begin title 102
REFERENCES
###end title 102
###begin article-title 103
Ligand-induced, receptor-mediated dimerization and activation of EGF receptor.
###end article-title 103
###begin article-title 104
An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor.
###end article-title 104
###begin article-title 105
###xml 35 40 <span type="species:ncbi:9606">human</span>
The EGFR family and its ligands in human cancer. Signalling mechanisms and therapeutic opportunities.
###end article-title 105
###begin article-title 106
A quantitative protein interaction network for the ErbB receptors using protein microarrays.
###end article-title 106
###begin article-title 107
Phosphotyrosine interactome of the ErbB receptor kinase family.
###end article-title 107
###begin article-title 108
Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics.
###end article-title 108
###begin article-title 109
Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules.
###end article-title 109
###begin article-title 110
Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks.
###end article-title 110
###begin article-title 111
Quantitative proteomic assessment of very early cellular signaling events.
###end article-title 111
###begin article-title 112
Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.
###end article-title 112
###begin article-title 113
Dynamic profiling of the post-translational modifications and interaction partners of epidermal growth factor receptor signaling after stimulation by epidermal growth factor using Extended Range Proteomic Analysis (ERPA).
###end article-title 113
###begin article-title 114
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
Differential phosphoprofiles of EGF and EGFR kinase inhibitor-treated human tumor cells and mouse xenografts.
###end article-title 114
###begin article-title 115
Epidermal growth factor receptor threonine and serine residues phosphorylated in vivo.
###end article-title 115
###begin article-title 116
Quantitation of multisite EGF receptor phosphorylation using mass spectrometry and a novel normalization approach.
###end article-title 116
###begin article-title 117
Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells.
###end article-title 117
###begin article-title 118
Epidermal growth factor receptor interaction with clathrin adaptors is mediated by the Tyr974-containing internalization motif.
###end article-title 118
###begin article-title 119
p38 MAP kinase mediates stress-induced internalization of EGFR: implications for cancer chemotherapy.
###end article-title 119
###begin article-title 120
Identification of EGF receptor C-terminal sequences 1005-1017 and di-leucine motif 1010LL1011 as essential in EGF receptor endocytosis.
###end article-title 120
###begin article-title 121
Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain.
###end article-title 121
###begin article-title 122
Transient suppression of ligand-mediated activation of epidermal growth factor receptor by tumor necrosis factor-alpha through the TAK1-p38 signaling pathway.
###end article-title 122
###begin article-title 123
p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration.
###end article-title 123
###begin article-title 124
Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19orf19 becomes tyrosine phosphorylated and associated with activated epidermal growth factor receptor.
###end article-title 124
###begin article-title 125
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
###end article-title 125
###begin article-title 126
Requirement for the adapter protein GRB2 in EGF receptor endocytosis.
###end article-title 126
###begin article-title 127
The serine/threonine kinase cyclin G-associated kinase regulates epidermal growth factor receptor signaling.
###end article-title 127
###begin article-title 128
Control of epidermal growth factor receptor endocytosis by receptor dimerization, rather than receptor kinase activation.
###end article-title 128
###begin article-title 129
Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.
###end article-title 129
###begin article-title 130
A statistical model for identifying proteins by tandem mass spectrometry.
###end article-title 130
###begin article-title 131
Analyzing chromatin remodeling complexes using shotgun proteomics and normalized spectral abundance factors.
###end article-title 131
###begin article-title 132
Quantitative proteomic analysis of distinct mammalian Mediator complexes using normalized spectral abundance factors.
###end article-title 132
###begin article-title 133
Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution.
###end article-title 133
###begin article-title 134
Multiple reaction monitoring as a method for identifying protein posttranslational modifications.
###end article-title 134
###begin article-title 135
Multiple reaction monitoring to identify sites of protein phosphorylation with high sensitivity.
###end article-title 135
###begin article-title 136
A quantitative results-driven approach to analyzing multisite protein phosphorylation: the phosphate-dependent phosphorylation profile of the transcription factor Pho4.
###end article-title 136
###begin article-title 137
LC/MS and LC/MS/MS screening for the sites of posttranslational modifications in proteins, in
###end article-title 137
###begin article-title 138
###xml 69 93 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae.
###end article-title 138
###begin article-title 139
Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database.
###end article-title 139
###begin article-title 140
Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor.
###end article-title 140
###begin article-title 141
###xml 49 54 <span type="species:ncbi:9606">human</span>
Comparison of label-free methods for quantifying human proteins by shotgun proteomics.
###end article-title 141
###begin article-title 142
###xml 23 28 <span type="species:ncbi:9606">human</span>
Large-scale mapping of human protein-protein interactions by mass spectrometry.
###end article-title 142
###begin article-title 143
A structural explanation for the recognition of tyrosine-based endocytotic signals.
###end article-title 143
###begin article-title 144
L1 endocytosis is controlled by a phosphorylation-dephosphorylation cycle stimulated by outside-in signaling by L1.
###end article-title 144
###begin article-title 145
Cbl-mediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is dispensable for endocytosis.
###end article-title 145
###begin article-title 146
Growth factor receptor binding protein 2-mediated recruitment of the RING domain of Cbl to the epidermal growth factor receptor is essential and sufficient to support receptor endocytosis.
###end article-title 146
###begin article-title 147
Ubc4/5 and c-Cbl continue to ubiquitinate EGF receptor after internalization to facilitate polyubiquitination and degradation.
###end article-title 147
###begin article-title 148
A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling.
###end article-title 148
###begin article-title 149
Endocytosis of epidermal growth factor receptor regulated by Grb2-mediated recruitment of the Rab5 GTPase-activating protein RN-tre.
###end article-title 149
###begin article-title 150
Role of Grb2 in EGF-stimulated EGFR internalization.
###end article-title 150
###begin article-title 151
Grb2 regulates internalization of EGF receptors through clathrin-coated pits.
###end article-title 151
###begin article-title 152
The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling.
###end article-title 152
###begin article-title 153
Epidermal growth factor receptor and cancer: control of oncogenic signalling by endocytosis.
###end article-title 153

